Fresenius is a health care group operating with products and services for dialysis, the hospital and the ambulatory medical care of patients. The Company operates five business segments: Fresenius Medical Care; Fresenius Kabi; Fresenius Helios; Fresenius Vamed, and Corporate/Other, which mainly comprises the holding functions of the Company Fresenius Medical Care provides dialysis care and dialysis products for patients with chronic kidney failure. Fresenius Kabi is engaged in the provision of generic drugs, infusion therapies, clinical nutrition, and related medical services. Fresenius Vamed realizes projects and services for hospitals and health care facilities. Fresenius Helios is a hospital operator.
Data provided by Mergent, Inc.
Powered by Interactive Data Managed Solutions
Data provided by Thomson Reuters, Inc.
| DR Symbol | FSNUY |
| CUSIP | 35804M105 |
| DR Exchange | OTC |
| DR ISIN | US35804M1053 |
| Ratio | 8:1 |
| Depositary | DB (Sponsored) |
| Effective Date | Oct 26, 2011 |
| Country | Germany |
| Industry | Pharma. & Biotech. |
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
Apr. 13 |
15.61 | 55,510 | 2,643 |
Mar. 13 |
15.50 | 90,615 | 4,531 |
Feb. 13 |
15.38 | 58,133 | 3,230 |
Related links |
Helpful Links |